Voyager IV-Delivered CNS Gene Therapies Featured in Multiple Presentations at ASGCT 2026, Including Late Breaker on Tau-Targeted VY1706 for Alzheimer’s Disease

Go back to Voyager IV-Delivered CNS Gene Therapies Featured in Multiple Presentations at ASGCT 2026, Including Late Breaker on Tau-Targeted VY1706 for Alzheimer’s Disease
(NASDAQ: VYGR) Delayed: 3.50 +0.04 (1.16%)
Previous Close $3.46    52 Week High $30.54 
Open $3.43    52 Week Low $8.12 
Day High $3.60    P/E N/A 
Day Low $3.43    EPS $0.00 
Volume 540,804